EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Comparing simultaneous hybrid ablation with stand-alone thoracoscopic surgical ablation for the treatment of non-paroxysmal atrial fibrillation: a prospective randomized controlled trial

Zhe Zheng iD, Yan Yao iD, Haojie Li, Chunyu Yu iD, Lihui Zheng iD, Ligang Ding, Lingmin Wu, Sipeng Chen iD, Hengqiang Lin, Ying Meng

Europace · 2024

DOI: 10.1093/europace/euae226 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2024. Verfasst von Zhe Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Recurrence, Thoracoscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Advanced atrial fibrillation (AF) is currently a dilemma for electrophysiologists when choosing a minimally invasive treatment strategy. Previous studies have demonstrated the outcome of either catheter ablation or thoracoscopic surgical ablation (SA) is unsatisfactory in these patients. Whether hybrid ablation (HA) could improve outcomes in these patients is unknown. The purpose of this study was to evaluate the clinical efficacy of HA for the treatment of advanced AF. Methods and results A randomized controlled trial was designed to enrol patients with persistent AF (PerAF) and enlarged left atrium or long-standing persistent AF (LSPAF) who were randomized to HA or thoracoscopic SA at a 1:1 ratio. The primary endpoint was freedom from any recurrence of AF off antiarrhythmic drugs (AADs) 12 months after operation. The primary endpoint was monitored by 7-day electrocardiogram monitoring devices. One hundred patients were enrolled. The mean age was 58.5 ± 7.6 years, and the mean left atrial diameter (LAD) was 50.1 ± 6.1 mm. At 12 months, freedom from AF off AADs was recorded in 71.4% (35/49) of patients in HA group and 45.8% (22/48) in SA group [odds ratio 2.955, 95% confidence interval (1.275–6.848), P = 0.014]. HA significantly reduced patients’ AF burden (30.2% in SA group and 14.8% in HA group, P = 0.048) and the LAD (mean differences: −5.53 ± 4.97 mm in HA group and −3.27 ± 5.20 mm in SA group, P = 0.037) at 12 months after operation.

Conclusion

In patients with PerAF and enlarged left atrium or LSPAF, HA achieved better freedom from AF after 1 year of follow-up compared with thoracoscopic SA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationRecurrenceThoracoscopyHumansMaleFemaleMiddle AgedProspective StudiesTreatment OutcomePulmonary VeinsAnti-Arrhythmia AgentsAgedTime FactorsElectrocardiography, Ambulatory

Stichwörter der Autor:innen

Atrial fibrillationSimultaneous hybrid ablationThoracoscopic surgical ablation

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Rd, Xicheng District, B…
  • Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Rd, Xicheng District, Beijing 100…
  • Department of Arrhythmia, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Rd, Xicheng District, Beijing 100037, People'…
  • Department of Information Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, People's Republic of China.

ORCID-Profile: Zhe Zheng, Yan Yao, Chunyu Yu, Lihui Zheng, Sipeng Chen

Förderung

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Zitieren

APA

Zheng, Z., Yao, Y., Li, H., Yu, C., Zheng, L., Ding, L., Wu, L., Chen, S., Lin, H., & Meng, Y. (2024). Comparing simultaneous hybrid ablation with stand-alone thoracoscopic surgical ablation for the treatment of non-paroxysmal atrial fibrillation: a prospective randomized controlled trial. Europace. https://doi.org/10.1093/europace/euae226

Vancouver

Zheng Z, Yao Y, Li H, Yu C, Zheng L, Ding L, et al. Comparing simultaneous hybrid ablation with stand-alone thoracoscopic surgical ablation for the treatment of non-paroxysmal atrial fibrillation: a prospective randomized controlled trial. Europace. 2024. doi:10.1093/europace/euae226

BibTeX
@article{Zheng2024,
  author = {Zheng, Zhe and Yao, Yan and Li, Haojie and Yu, Chunyu and Zheng, Lihui and Ding, Ligang and Wu, Lingmin and Chen, Sipeng and Lin, Hengqiang and Meng, Ying},
  title = {Comparing simultaneous hybrid ablation with stand-alone thoracoscopic surgical ablation for the treatment of non-paroxysmal atrial fibrillation: a prospective randomized controlled trial},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae226}
}
Kostenlos starten →